The document summarizes several highlights from the 2014 ASCO conference: 1) The ALTTO trial showed impressive 4-year disease-free survival rates of 95-94% for different early breast cancer treatment groups including chemotherapy, hormone therapy, and their combinations. 2) A study at MD Anderson found that an AI system called Oncology Expert Advisor was able to recommend standard-of-care cancer treatments over 80% of the time based on patient cases. 3) An IOM report found that the gaps in cancer care are expanding due to a growing cancer population and shortage of oncology professionals, emphasizing the need for improved communication between doctors and patients. 4) A study found obese